Table 1_Clinical risk factors and genomic characterization of carbapenem-resistant Klebsie

A retrospective study of 233 patients with carbapenem-resistant Klebsiella pneumoniae infections at a tertiary Traditional Chinese Medicine hospital between 2019 and 2022. The dataset likely contains clinical risk factors for mortality and genomic sequencing results for 102 isolates, authored by Wenxia Zhang and published in 2026.

Use Cases

• Predicting mortality risk based on clinical factors like sepsis and ICU admission mentioned in the description.
• Analyzing the prevalence of specific bacterial clones (e.g., ST11-KL64) and their genomic determinants.
• Investigating the association between plasmid types (e.g., IncFIB(K)) and antimicrobial resistance genes.
• Studying the co-occurrence of virulence factors (aerobactin, salmochelin, yersiniabactin) in high-virulence strains.

Strengths

• Includes 233 patient records with mortality outcomes.
• Contains genomic sequencing data for 102 bacterial isolates.
• Provides specific odds ratios for four independent mortality risk factors.
• Identifies dominant clones (ST11-KL64 at 55.9%) and primary resistance gene (blaKPC-2 at 92.2%).

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data may reflect geographic bias inherent to a single hospital study.

Provenance

Source

figshare

Collection Method

Retrospective study and whole-genome sequencing.

Time Range

2019 to 2022

Freshness

Last updated 2026-05-25 06:05:25; freshness should be verified.

Geography

A tertiary Traditional Chinese Medicine hospital in China.